What is the most recent earnings date for TEVA stock?
TEVA PHARMACEUTICAL-SP ADR (TEVA) last reported earnings on 1/28/2026.
TEVA PHARMACEUTICAL-SP ADR (TEVA) Earnings History & Surprises
NYSE:TEVA • US8816242098
Current stock price
29.44 USD
-0.17 (-0.57%)
At close:
29.2267 USD
-0.21 (-0.72%)
After Hours:
TEVA Earnings overview
Past quarterly earnings results for TEVA PHARMACEUTICAL-SP ADR (TEVA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.54
- Revenue Estimate
- 3.877B
Last Reported
Most Recent- Release Date
- Jan 28, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.98
- EPS Surprise
- 38.54%
- Revenue Surprise
- 5.75%
Beat Rate
Last 8 Quarters 75%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.98 | 0.71 | 38.54% | 35.21% | 4.711B | 4.455B | 5.75% | 11.40% |
| Q3 2025 | 0.79 | 0.68 | 16.51% | 13.04% | 4.48B | 4.44B | 0.90% | 3.42% |
| Q2 2025 | 0.67 | 0.64 | 4.65% | 8.20% | 4.176B | 4.385B | -4.77% | 0.29% |
| Q1 2025 | 0.53 | 0.50 | 5.84% | 8.33% | 3.891B | 4.082B | -4.68% | 1.89% |
| Q4 2024 | 0.72 | 0.71 | 2.01% | -29.00% | 4.229B | 4.203B | 0.62% | -5.12% |
| Q3 2024 | 0.70 | 0.68 | 3.02% | 15.00% | 4.332B | 4.221B | 2.63% | 12.52% |
| Q2 2024 | 0.62 | 0.59 | 4.92% | 8.93% | 4.164B | 4.13B | 0.82% | 7.49% |
| Q1 2024 | 0.49 | 0.54 | -8.98% | 20.00% | 3.819B | 3.834B | -0.39% | 4.15% |
| Q4 2023 | 1.02 | 0.79 | 28.49% | 40.85% | 4.457B | 4.074B | 9.40% | 14.75% |
| Q3 2023 | 0.61 | 0.62 | -1.59% | 1.69% | 3.85B | 3.794B | 1.48% | 7.09% |
| Q2 2023 | 0.57 | 0.55 | 3.64% | -17.65% | 3.874B | 3.764B | 2.92% | 2.32% |
| Q1 2023 | 0.41 | 0.59 | -30.51% | -27.27% | 3.667B | 3.717B | -1.35% | 0.16% |
| Q4 2022 | 0.72 | 0.79 | -8.41% | -7.79% | 3.884B | 3.98B | -2.41% | -5.27% |
| Q3 2022 | 0.60 | 0.65 | -7.45% | - | 3.595B | 3.948B | -8.94% | -7.51% |
| Q2 2022 | 0.69 | 0.62 | 11.11% | 15.25% | 3.786B | 3.93B | -3.66% | -3.17% |
| Q1 2022 | 0.56 | 0.63 | -11.60% | -12.70% | 3.661B | 3.966B | -7.69% | -8.06% |
| Q4 2021 | 0.78 | 0.75 | 4.85% | 13.24% | 4.1B | 4.388B | -6.56% | -7.93% |
| Q3 2021 | 0.60 | 0.67 | -9.62% | 1.72% | 3.887B | 4.077B | -4.66% | -2.29% |
| Q2 2021 | 0.60 | 0.65 | -8.19% | 7.27% | 3.91B | 4.168B | -6.19% | 1.03% |
| Q1 2021 | 0.64 | 0.63 | 1.25% | - | 3.982B | 4.144B | -3.91% | -8.61% |
| Q4 2020 | 0.69 | 0.65 | 5.82% | - | 4.453B | 4.428B | 0.56% | - |
| Q3 2020 | 0.59 | 0.61 | -3.62% | - | 3.978B | 4.129B | -3.66% | - |
| Q2 2020 | 0.56 | 0.62 | -10.13% | - | 3.87B | 4.194B | -7.73% | - |
| Q1 2020 | - | - | 4.357B | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
16.39%
Max EPS beat (4)
38.54%
Min EPS beat (4)
4.65%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-0.70%
Max Revenue beat (4)
5.75%
Min Revenue beat (4)
-4.77%
Analysis
In the last 4 quarters, TEVA has consistently beaten EPS estimates in all releases
TEVA has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, TEVA has beaten the EPS estimates by 16.4% on average.
In the last 4 quarters, TEVA reported -0.7% below the revenue estimates on average.
Related analysis
TEVA PHARMACEUTICAL-SP ADR / TEVA Earnings FAQ
Did TEVA PHARMACEUTICAL-SP ADR (TEVA) beat earnings estimates last quarter?
TEVA PHARMACEUTICAL-SP ADR (TEVA) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often TEVA PHARMACEUTICAL-SP ADR beats earnings estimates?
In the last 4 quarters, TEVA PHARMACEUTICAL-SP ADR (TEVA) has beaten EPS estimates in 4 out of 4 releases.